MANGALAM · Mangalam Drugs And Organics Limited · Financials
Volume · Nov 13
406
Avg daily vol (14 sessions)
1804
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
2.32B
-27.1%
FY2026
Net Income
0
FY2026
Operating Cash Flow
41.78M
-90.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| INR | 2.62B | 2.32B | 3.18B | 3.69B |
| INR | 173.23M | 182.23M | 166.07M | 146.51M |
| INR | 146.98M | 162.08M | 149.33M | 139.17M |
| INR | -388.43M | -485.71M | 47.86M | -110.73M |
| INR | -7.41M | -41.71M | -19.35M | -20.02M |
| INR | -98.36M | 0 | 0 | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.